Difference between revisions of "Ankyrin"

From MyMediaWiki
Jump to: navigation, search
m
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
! {{infobox header}}| '''{{PAGENAME}}'''  
+
! {infobox header}| '''{{PAGENAME}}'''  
|-
 
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
 
 
|-
 
|-
 
| Substrate peptide name
 
| Substrate peptide name
Line 35: Line 33:
 
|-
 
|-
 
| Surface accessibility
 
| Surface accessibility
| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
+
|  
 
|-
 
|-
 
| Disorder prediction
 
| Disorder prediction
Line 47: Line 45:
 
|  
 
|  
 
|-
 
|-
| {{infobox header}} |  
+
| {infobox header} |  
 
|-
 
|-
 
|}
 
|}
  
 
[[Category:Tissue transglutaminase|*]]
 
[[Category:Tissue transglutaminase|*]]

Latest revision as of 11:24, 10 March 2015

Ankyrin
Substrate peptide name Ankyrin
Synonyms -
Determination type In situ/In vitro
Source Homo sapiens
Subcellular localization Erythrocyte cytoskeleton
Swissprot ID P16157
Reactive glutamines Not determined yet
Reactive lysines Not determined yet
Substrate sequence
Structure 1N11
Surface accessibility
Disorder prediction IUPred
Reference PMID:2881577

PMID:12563291

Notes